In 2003, Abbott acquired JOMED's coronary and peripheral intervention business lines, and entered the healthy-living nutrition category with ZonePerfect Nutritional Co. "Throughout the 2000s ...

O'Melveny & Myers is defending Abbott Laboratories in a pending class action against the company and two other co-defendants, ...

The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body doesn't produce enough insulin or i ...

Summary. In 2008 Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...

This was the stock's third consecutive day of losses.

Abbott Laboratories closed $4.01 short of its 52-week high ($121.64), which the company reached on March 8th.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $133.00. The company’s shares ...

Abbott (ABT) closed the most recent trading day at $113.70, moving -0.39% from the previous trading session. Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Abbott Elementary: L-R: William Stanford Davis, Lisa Ann Walter, Tyler James Williams, Sheryl Lee Ralph, Chris Perfetti, Janelle James, Quinta Brunson (front/center) ABC EXCLUSIVE: ABC’s Abbott ...